TIDMMDC TIDM80GT
RNS Number : 4517V
Mediclinic International plc
09 August 2022
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
South African income tax number: 9432434182
('Mediclinic', the 'Company', or the 'Group')
9 August 2022
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00B8HX8Z88
Issuer Name
MEDICLINIC INTERNATIONAL PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights; An acquisition or
disposal of financial instruments
3. Details of person subject to the notification obligation
Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name City of registered office Country of registered office
J.P. Morgan Securities
=========================== ==============================
5. Date on which the threshold was crossed or reached
05-Aug-2022
6. Date on which Issuer notified
09-Aug-2022
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 4.232665 4.881712 9.114377 67195773
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 1.308596 7.723660 9.032256
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00B8HX8Z88 31205499 4.232665
====================== ====================== ====================== ======================
Sub Total 8.A 31205499 4.232665%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Cash-settled
Equity Swap 23/11/2022 23/11/2022 Cash 28558635 3.873700
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 01/02/2023 01/02/2023 Cash 16152 0.002190
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 22/02/2023 22/02/2023 Cash 20437 0.002771
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 17/03/2023 17/03/2023 Cash 28523 0.003868
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 02/06/2023 02/06/2023 Cash 143409 0.019452
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 04/07/2023 04/07/2023 Cash 7109658 0.964353
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 12/07/2023 12/07/2023 Cash 13127 0.001779
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 09/08/2023 09/08/2023 Cash 759 0.000102
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 16/08/2023 16/08/2023 Cash 2400 0.000324
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 21/08/2023 21/08/2023 Cash 526 0.000070
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 22/08/2023 22/08/2023 Cash 598 0.000081
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 06/07/2027 06/07/2027 Cash 309 0.000041
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 03/08/2027 03/08/2027 Cash 289 0.000038
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 09/07/2029 09/07/2029 Cash 65281 0.008853
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 12/02/2024 12/02/2024 Cash 13023 0.001766
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 06/09/2023 06/09/2023 Cash 13795 0.001870
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 07/09/2023 07/09/2023 Cash 3353 0.000454
================ ==================== ================== ================== ==================
Sub Total 8.B2 35990274 4.881712%
================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is higher through financial equals or is higher
than the notifiable instruments if it than the notifiable
threshold equals or is higher threshold
than the notifiable
threshold
JPMorgan Chase & Co. J.P. Morgan Securities plc 4.881712 7.180133%
=============================================== ===================== =====================
JPMorgan Chase & Co. JPMorgan Chase Bank, National Association
=============================================== ===================== =====================
JPMorgan Chase & Co. J.P. Morgan Equities South Africa
Proprietary Limited
=============================================== ===================== =====================
JPMorgan Chase & Co. J.P. Morgan SE
=============================================== ===================== =====================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Equities South Africa Proprietary Limited (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)
12. Date of Completion
09-Aug-2022
13. Place Of Completion
London
About Mediclinic International plc
Mediclinic is a diversified international private healthcare
services group, established in South Africa in 1983, with divisions
in Switzerland, Southern Africa (South Africa and Namibia) and the
Middle East.
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for
all their healthcare needs.
Mediclinic is focused on providing specialist-orientated,
multi-disciplinary services across the continuum of care in such a
way that the Group will be regarded as the most respected and
trusted provider of healthcare services by patients, medical
practitioners, funders and regulators of healthcare in each of its
markets.
At 30 June 2022, Mediclinic comprised 74 hospitals, five
subacute hospitals, two mental health facilities, 20 day case
clinics and 23 outpatient clinics. The Swiss operations included 17
hospitals and four day case clinics with around 1 900 inpatient
beds; Southern Africa operations included 50 hospitals (three of
which in Namibia), five subacute hospitals, two mental health
facilities and 14 day case clinics (four of which operated by
Intercare) across South Africa, and around 8 650 inpatient beds;
and the Middle East operated seven hospitals, two day case clinics
and 23 outpatient clinics with around 1 000 inpatient beds in the
UAE. In addition, under management contract the Middle East will
open a 200-bed hospital in the Kingdom of Saudi Arabia in 2023.
The Company's primary listing is on the London Stock Exchange
("LSE") in the United Kingdom, with secondary listings on the JSE
in South Africa and the Namibian Stock Exchange in Namibia.
Mediclinic also holds a 29.7% interest in Spire Healthcare Group
plc, a leading private healthcare group based in the United Kingdom
and listed on the LSE.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Caroline Emmet
+44 (0)333 300 1930
Investor Relations
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Ben Atwell/Ciara Martin - United Kingdom
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address : 6(th) Floor, 65 Gresham Street, London,
EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Corporate broker (United Kingdom) : Morgan Stanley & Co
International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of
FirstRand Bank Limited)
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUKVORUUUWRAR
(END) Dow Jones Newswires
August 09, 2022 09:57 ET (13:57 GMT)
Mediclinic (LSE:MDC)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Mediclinic (LSE:MDC)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024